人骨髓基质细胞外泌体改善牙周炎
本研究从人骨髓基质细胞(hBMSC)培养液中分离外泌体,用RNA测序和蛋白芯片表征其富集的miRNA和蛋白。体外实验显示hBMSC外泌体显著抑制牙龈卟啉单胞菌触发的巨噬细胞炎症反应;大鼠结扎诱导牙周炎模型中每周注射外泌体可减少组织破坏和免疫细胞浸润。结果提示hBMSC外泌体可能作为宿主调节剂用于牙周炎管理。
要点
- hBMSC外泌体显著抑制牙龈卟啉单胞菌触发的巨噬细胞炎症反应。
- 大鼠结扎诱导牙周炎模型中每周注射外泌体减少组织破坏和免疫细胞浸润。
- hBMSC外泌体可能作为宿主调节剂用于牙周炎管理。
核心结论
- hBMSC来源外泌体可能作为宿主调节剂用于牙周炎管理。
研究设计与样本
- 从细胞培养液经连续超速离心分离hBMSC外泌体,用RNA测序和蛋白芯片分别表征富集的miRNA和蛋白。
主要发现
- hBMSC外泌体显著抑制牙龈卟啉单胞菌触发的巨噬细胞炎症反应。
- 转录组分析提示外泌体通过调节细胞代谢、分化和炎症消退发挥作用。
- 大鼠结扎诱导牙周炎模型中每周向牙龈组织注射外泌体减少组织破坏和免疫细胞浸润。
临床怎么用
- 作者认为hBMSC来源外泌体可能作为宿主调节剂用于牙周炎管理。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Human bone marrow stromal cell (hBMSC)-derived exosomes are promising therapeutics for inflammatory diseases due to their unique microRNA (miRNA) and protein cargos. Periodontal diseases often present with chronicity and corresponding exuberant inflammation, which leads to loss of tooth support. In this study, we explored whether hBMSC exosomes can affect periodontitis progression. hBMSC exosomes were isolated from cell culture medium through sequential ultracentrifugation. miRNAs and proteins that were enriched in hBMSC exosomes were characterized by RNA sequencing and protein array, respectively. hBMSC exosomes significantly suppressed periodontal keystone pathogen Porphyromonas gingivalis-triggered inflammatory response in macrophages in vitro. Transcriptomic analysis suggested that exosomes exerted their effects through regulating cell metabolism, differentiation, and inflammation resolution. In vivo, weekly exosome injection into the gingival tissues reduced the tissue destruction and immune cell infiltration in rat ligature-induced periodontitis model. Collectively, these findings suggest that hBMSC-derived exosomes can potentially be used as a host modulation agent in the management of periodontitis.
引用
- Yue C, Cao J, Wong A, et al. Human Bone Marrow Stromal Cell Exosomes Ameliorate Periodontitis. J Dent Res. 2022. PMID: 35356822. doi:10.1177/00220345221084975
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。